E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours

European Journal of Cancer

Volumn 39, Issue 4, 2003, Pages 517-523

  Chen, C L ^a   Liu, S S ^b   Ip, S M ^b   Wong, L C ^b   Ng, T Y ^c   Ngan, H Y S ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c NONE

Author keywords

Antisense oligonucleotide; Cervical cancer; E cadherin; Methylation; Methyltransferase; MSP

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; METHYLTRANSFERASE; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BLOTTING, WESTERN; CADHERINS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ENZYME INHIBITORS; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0037363349     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00175-2     Document Type: Article

References (32)

1. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153:1998;333-339.
2. Debruyne P., Vermeulen S., Mareel M. The role of the E-cadherin/catenin complex in gastrointestinal cancer. Acta. Gastroenterol. Belg. 62:1999;393-402.
3. Bussemakers M.J., Van Bokhoven A., Tomita K., Jansen C.F., Schalken J.A. Complex cadherin expression in human prostate cancer cells. Int. J. Cancer. 85:2000;446-450.
4. Graff J.R., Herman J.G., Lapidus R.G.et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55:1995;5195-5199.
5. Yoshiura K., Kanai Y., Ochiai A., Shimoyama Y., Sugimura T., Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA. 92:1995;7416-7419.
6. Kanai Y., Ushijima S., Hui A.M.et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer. 71:1997;355-359.
7. Graff J.R., Greenberg V.E., Herman J.G.et al. Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Cancer Res. 58:1998;2063-2066.
8. Hennig G., Behrens J., Truss M., Frisch S., Reichmann E., Birchmeier W. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene. 11:1995;475-484.
9. Bachman K.E., Herman J.G., Corn P.G.et al. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res. 59:1999;798-802.
10. Herman J.G., Umar A., Polyak K.et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA. 95:1998;6870-6875.
11. Toyota M., Ahuja N., Suzuki H.et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59:1999;5438-5442.
12. Bestor T.H. Cloning of a mammalian DNA methyltransferase. Gene. 74:1988;9-12.
13. Issa J.P., Vertino P.M., Wu J.et al. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J. Natl. Cancer Inst. 85:1993;1235-1240.
14. Sun L., Hui A.M., Kanai Y., Sakamoto M., Hirohashi S. Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis. Jpn. J. Cancer Res. 88:1997;1165-1170.
15. Kanai Y., Ushijima S., Kondo Y., Nakanishi Y., Hirohashi S. DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int. J. Cancer. 91:2001;205-212.
16. Ramchandani S., MacLeod A.R., Pinard M., von Hofe E., Szyf M. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA. 94:1997;684-689.
17. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 99:1999;247-257.
18. Denk C., Hulsken J., Schwarz E. Reduced gene expression of E-cadherin and associated catenins in human cervical carcinoma cell lines. Cancer Lett. 120:1997;185-193.
19. Jeffers M.D., Paxton J., Bolger B., Richmond J.A., Kennedy J.H., McNicol A.M. E-cadherin and integrin cell adhesion molecule expression in invasive and in situ carcinoma of the cervix. Gynecol. Oncol. 64:1997;481-486.
20. Fujimoto J., Ichigo S., Hirose R., Sakaguchi H., Tamaya T. Expression of E-cadherin and alpha- and beta-catenin mRNAs in uterine cervical cancers. Tumour Biol. 18:1997;206-212.
21. de Boer C.J., van Dorst E., van Krieken H.et al. Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am. J. Pathol. 155:1999;505-515.
22. Vessey C.J., Wilding J., Folarin N.et al. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J. Pathol. 176:1995;151-159.
23. Fournel M., Sapieha P., Beaulieu N., Besterman J.M., MacLeod A.R. Down-regulation of human DNA-(cytosine-5) methyltransferase induces cell cycle regulators p16(ink4A) and p21(WAF/Cip1) by distinct mechanisms. J. Biol. Chem. 274:1999;24250-24256.
24. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR. a novel PCR assay for methylation status of CpG islands Proc. Natl. Acad. Sci. USA. 93:1996;9821-9826.
25. Krul E.J., Kersemaekers A.M., Zomerdijk-Nooyen Y.A., Cornelisse C.J., Peters L.A., Fleuren G.J. Different profiles of allelic losses in cervical carcinoma cases in Surinam and The Netherlands. Cancer. 86:1999;997-1004.
26. Ji X., Woodard A.S., Rimm D.L., Fearon E.R. Transcriptional defects underlie loss of E-cadherin expression in breast cancer. Cell Growth Differ. 8:1997;773-778.
27. El Deiry W.S., Nelkin B.D., Celano P.et al. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc. Natl. Acad. Sci. USA. 88:1991;3470-3474.
28. Chen B., Liu X., Savell V.H.et al. Erratum. increased DNA methyltransferase expression in rhabdomyosarcomas Int. J. Cancer. 83:1999;874.
29. Eads C.A., Danenberg K.D., Kawakami K., Saltz L.B., Danenberg P.V., Laird P.W. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res. 59:1999;2302-2306.
30. Jurgens B., Schmitz-Drager B.J., Schulz W.A. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res. 56:1996;5698-5703.
31. Jackson-Grusby L., Laird P.W., Magge S.N., Moeller B.J., Jaenisch R. Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase. Proc. Natl. Acad. Sci. USA. 94:1997;4681-4685.
32. Chuang L.S., Ian H.I., Koh T.W., Ng H.H., Xu G., Li B.F. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science. 277:1997;1996-2000.